This little-recognized sleep disorder has no currently approved therapies. But lower-sodium oxybate was so life-changing for some patients in clinical trials that they wanted to stay on the drug afterward.
A preliminary analysis finds both complementary and distinctive relationships between circadian and sleep disruptions and biomarkers of immunity and inflammation in people with Alzheimer’s disease.
Sleep interventions may help improve quality of life of patients with both endometrial cancer and obesity, a new Case Comprehensive Cancer Center study finds. Co-authors Jay Alberts, PhD, and Chad Michener, MD, explain.
Sleep disorders expert Nancy Foldvary-Schaefer, DO, shares thoughts on incorporating sleep management into routine neurological care — and how clinicians can boost their own sleep health.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Our web-based Go! to Sleep program is bringing CBT to patients for whom in-person treatment can be challenging. It’s now proving effective in diverse populations with chronic conditions that undermine sleep.
Our Sleep Disorders Center is using the funds to create a first-of-kind sleep biophysiologic repository leveraging over 100,000 sleep studies and to study links between sleep apnea and QT prolongation.
Findings from a large neurological outpatient sample raise the prospect of studying sleep therapies for their effect on disease-specific outcomes in a range of neurological conditions.
An innovative group-therapy approach to promoting PAP treatment adherence is proving its worth as outcomes data mount.
Cleveland Clinic has started screening all patients with epilepsy for obstructive sleep apnea — and treating them with PAP if they test positive. Findings from this newly presented study explain why.
A sleep disorders expert gives context to the work behind the Nobel Prize in Medicine — and looks to how it may shape future research.